CMV
2
Pipeline Programs
5
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
1100%
+ 6 programs with unclassified modality
Competitive Landscape
5 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Jazz PharmaceuticalsBrincidofovir
Merck & Co.Real time PCR
QIAGENQuantiFERON CMV Assay
Clinical Trials (3)
Total enrollment: 860 patients across 3 trials
A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients
Start: Aug 2013Est. completion: Jan 2016452 patients
Phase 3Completed
Cytomegalovirus Infection in Critically Ill Patients and Patients Receiving Anticancer Therapy
Start: Mar 2020Est. completion: Dec 2022400 patients
N/AUnknown
Clinical Evaluation of the QuantiFERON CMV Assay
Start: Nov 2018Est. completion: Jun 20208 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
5 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.